BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7978805)

  • 1. A high throughput fluorogenic substrate for stromelysin (MMP-3).
    Bickett DM; Green MD; Wagner C; Roth JT; Berman J; McGeehan GM
    Ann N Y Acad Sci; 1994 Sep; 732():351-5. PubMed ID: 7978805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and characterization of a fluorogenic substrate selectively hydrolyzed by stromelysin 1 (matrix metalloproteinase-3).
    Nagase H; Fields CG; Fields GB
    J Biol Chem; 1994 Aug; 269(33):20952-7. PubMed ID: 8063713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel coumarin-labelled peptide for sensitive continuous assays of the matrix metalloproteinases.
    Knight CG; Willenbrock F; Murphy G
    FEBS Lett; 1992 Jan; 296(3):263-6. PubMed ID: 1537400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Mca-Lys-Pro-Leu-Gly-Leu-Dpa-Ala-Arg-NH2, a fluorogenic substrate with increased specificity constants for collagenases and tumor necrosis factor converting enzyme.
    Neumann U; Kubota H; Frei K; Ganu V; Leppert D
    Anal Biochem; 2004 May; 328(2):166-73. PubMed ID: 15113693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A high throughput fluorogenic substrate for interstitial collagenase (MMP-1) and gelatinase (MMP-9).
    Bickett DM; Green MD; Berman J; Dezube M; Howe AS; Brown PJ; Roth JT; McGeehan GM
    Anal Biochem; 1993 Jul; 212(1):58-64. PubMed ID: 8368516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the S1' subsite glutamine 215 in activity and specificity of stromelysin-3 by site-directed mutagenesis.
    Holtz B; Cuniasse P; Boulay A; Kannan R; Mucha A; Beau F; Basset P; Dive V
    Biochemistry; 1999 Sep; 38(37):12174-9. PubMed ID: 10508422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substrate specificity of the human matrix metalloproteinase stromelysin and the development of continuous fluorometric assays.
    Niedzwiecki L; Teahan J; Harrison RK; Stein RL
    Biochemistry; 1992 Dec; 31(50):12618-23. PubMed ID: 1472498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Highly increased levels of active stromelysin in rheumatoid synovial fluid determined by a selective fluorogenic assay.
    Beekman B; van El B; Drijfhout JW; Ronday HK; TeKoppele JM
    FEBS Lett; 1997 Dec; 418(3):305-9. PubMed ID: 9428733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quenched fluorescent substrate for thimet peptidase containing a new fluorescent amino acid, DL-2-amino-3-(7-methoxy-4-coumaryl)propionic acid.
    Knight CG
    Biochem J; 1991 Feb; 274 ( Pt 1)(Pt 1):45-8. PubMed ID: 2001250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and characterization of selective fluorescent ligands for the neurokinin NK2 receptor.
    Bradshaw CG; Ceszkowski K; Turcatti G; Beresford IJ; Chollet A
    J Med Chem; 1994 Jun; 37(13):1991-5. PubMed ID: 8027981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of a fluorogenic interleukin-1 beta converting enzyme substrate based on resonance energy transfer.
    Pennington MW; Thornberry NA
    Pept Res; 1994; 7(2):72-6. PubMed ID: 8012123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic characterization of lysine-specific metalloendopeptidases from Grifola frondosa and Pleurotus ostreatus fruiting bodies.
    Nonaka T; Hashimoto Y; Takio K
    J Biochem; 1998 Jul; 124(1):157-62. PubMed ID: 9644258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thioester hydrolysis by matrix metalloproteinases.
    Stein RL; Izquierdo-Martin M
    Arch Biochem Biophys; 1994 Jan; 308(1):274-7. PubMed ID: 8311464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification of human matrilysin produced in Escherichia coli and characterization using a new optimized fluorogenic peptide substrate.
    Welch AR; Holman CM; Browner MF; Gehring MR; Kan CC; Van Wart HE
    Arch Biochem Biophys; 1995 Dec; 324(1):59-64. PubMed ID: 7503560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuously recording fluorescent assays optimized for five human matrix metalloproteinases.
    Netzel-Arnett S; Mallya SK; Nagase H; Birkedal-Hansen H; Van Wart HE
    Anal Biochem; 1991 May; 195(1):86-92. PubMed ID: 1888020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convenient fluorometric assay for matrix metalloproteinase activity and its application in biological media.
    Beekman B; Drijfhout JW; Bloemhoff W; Ronday HK; Tak PP; te Koppele JM
    FEBS Lett; 1996 Jul; 390(2):221-5. PubMed ID: 8706864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A fluorescent peptide substrate for the surface metalloprotease of Leishmania.
    Bouvier J; Schneider P; Malcolm B
    Exp Parasitol; 1993 Mar; 76(2):146-55. PubMed ID: 8454023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a tight-binding MMP-3 inhibitor using improved fluorescence spectroscopy techniques.
    Finch-Arietta M; Johnson W; Lusch L; Fotouhi N; Walsky R; Hanglow AC
    Agents Actions; 1993; 39 Spec No():C189-91. PubMed ID: 8273564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Membrane type-1 matrix metalloprotease and stromelysin-3 cleave more efficiently synthetic substrates containing unusual amino acids in their P1' positions.
    Mucha A; Cuniasse P; Kannan R; Beau F; Yiotakis A; Basset P; Dive V
    J Biol Chem; 1998 Jan; 273(5):2763-8. PubMed ID: 9446583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanistic studies on the human matrix metalloproteinase stromelysin.
    Harrison RK; Chang B; Niedzwiecki L; Stein RL
    Biochemistry; 1992 Nov; 31(44):10757-62. PubMed ID: 1420192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.